EUVIMEDEUVIMED entdecken
MetaanalyseSystematische ÜbersichtOpen Access · CC BY 4.0

Psychopharmacology of eating disorders: Systematic review and meta-analysis of randomized controlled trials

Michele Fornaro, Anna Maria Mondin, Martina Billeci, Andrea Fusco, Michele De Prisco, Claudio Caiazza, Fausta Micanti, Raffaella Calati, André Férrer Carvalho, Andrea de Bartolomeis

Journal of Affective Disorders · 2023-10 · 338 · 526-545

DOI: 10.1016/j.jad.2023.06.068 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Journal of Affective Disorders, 2023-10. Verfasst von Michele Fornaro und 9 weiteren Autor:innen. Beteiligte Einrichtung: Section of Psychiatry - Department of Neuroscience, Reproductive Sciences, and Dentistry, University School of Medicine Federico II, Naples, Italy. E…. Hauptthemen laut MEDLINE: Psychopharmacology, Feeding and Eating Disorders, Bulimia Nervosa, Binge-Eating Disorder. Die Arbeit wurde bisher 53-mal zitiert (Crossref) und nennt 108 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The concurrent assessment of weight and affective psychopathology outcomes relevant to the psychopharmacology of major eating disorders (EDs), namely anorexia nervosa (AN), bulimia nervosa (BN), and binge eating disorder (BED), warrants systematic review and meta-analysis of randomized controlled trials (RCTs). METHODS: PubMed, Scopus, and ClinicalTrials.gov were inquired from inception through August 31st, 2022, for RCTs documenting any psychopharmacological intervention for EDs diagnosed according to validated criteria and reporting weight and psychopathology changes. Adopted keywords were: "anorexia nervosa," "bulimia nervosa," "binge eating disorder," "antidepressant," "antipsychotic," and "mood stabilizer." No language restriction applied. RESULTS: 5122 records were identified, and 203 full-texts were reviewed. Sixty-two studies entered the qualitative synthesis (AN = 22, BN = 23, BED = 17), of which 22 entered the meta-analysis (AN = 9, BN = 10, BED = 3). Concerning BMI increase in AN, olanzapine outperformed placebo (Hedges'g = 0.283, 95%C·I. = 0.051-0.515, I2 = 0 %; p = .017), whereas fluoxetine failed (Hedges'g = 0.351, 95%C.I. = -0.248 to 0.95, I2 = 63.37 %; p = .251). Fluoxetine not significantly changed weight (Hedges'g = 0.147, 95%C.I. = -0.157-0.451, I2 = 0 %; p = .343), reducing binging (Hedges'g = 0.203, 95%C.I. = 0.007-0.399, I2 = 0 %; p = .042), and purging episodes (Hedges'g = 0.328, 95%C.I. = -0.061-0.717, I2 = 58.97 %; p = .099) in BN. Lisdexamfetamine reduced weight (Hedges'g = 0.259, 95%C.I. = 0.071-0.446, I2 = 0 %; p = .007) and binging (Hedges'g = 0.571, 95%C.I. = 0.282-0.860, I2 = 53.84 %; p < .001) in BED. LIMITATIONS: Small sample size, short duration, and lack of reliable operational definitions affect most of the included sponsored RCTs. CONCLUSIONS: The efficacy of different drugs varies across different EDs, warranting additional primary studies recording broad psychopathological and cardiometabolic outcomes besides weight, especially against established psychotherapy interventions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PsychopharmacologyFeeding and Eating DisordersBulimia NervosaBinge-Eating DisorderAnorexia NervosaAntipsychotic AgentsHumansFluoxetineRandomized Controlled Trials as Topic

Stichwörter der Autor:innen

Anorexia nervosaBinge eating disorderBulimia nervosaPsychopharmacologySystematic reviewmeta-analysis

Substanzen

FluoxetineAntipsychotic Agents

Autor:innen und Institutionen

  • Section of Psychiatry - Department of Neuroscience, Reproductive Sciences, and Dentistry, University School of Medicine Federico II, Naples, Italy. Electronic address: dott.fornaro@gmail.com.
  • Section of Psychiatry - Department of Neuroscience, Reproductive Sciences, and Dentistry, University School of Medicine Federico II, Naples, Italy.
  • National Healthcare System, Naples, Italy.
  • Section of Psychiatry - Department of Neuroscience, Reproductive Sciences, and Dentistry, University School of Medicine Federico II, Naples, Italy; Bipolar and Depressive Disorders Unit, IDIBAPS CIBERSAM, Hospital Clini…
  • Department of Psychology, University of Milan-Bicocca, Piazza dell'Ateneo Nuovo, 1, 20126 Milan, Italy; Department of Adult Psychiatry, Nîmes University Hospital, 4 Rue du Professeur Robert Debré, 30029 Nimes, France. E…
  • Deakin University, IMPACT - the Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Barwon Health, Geelong, Australia; Florey Institute for Neuroscience and Mental Health, the Departme…

Zitieren

APA

Fornaro, M., Mondin, A. M., Billeci, M., Fusco, A., De Prisco, M., Caiazza, C., Micanti, F., Calati, R., Carvalho, A. F., & de Bartolomeis, A. (2023). Psychopharmacology of eating disorders: Systematic review and meta-analysis of randomized controlled trials. Journal of Affective Disorders, 338, 526-545. https://doi.org/10.1016/j.jad.2023.06.068

Vancouver

Fornaro M, Mondin AM, Billeci M, Fusco A, De Prisco M, Caiazza C, et al. Psychopharmacology of eating disorders: Systematic review and meta-analysis of randomized controlled trials. Journal of Affective Disorders. 2023;338:526-545. doi:10.1016/j.jad.2023.06.068

BibTeX
@article{Fornaro2023,
  author = {Fornaro, Michele and Mondin, Anna Maria and Billeci, Martina and Fusco, Andrea and De Prisco, Michele and Caiazza, Claudio and Micanti, Fausta and Calati, Raffaella and Carvalho, André Férrer and de Bartolomeis, Andrea},
  title = {Psychopharmacology of eating disorders: Systematic review and meta-analysis of randomized controlled trials},
  journal = {Journal of Affective Disorders},
  year = {2023},
  volume = {338},
  pages = {526--545},
  doi = {10.1016/j.jad.2023.06.068}
}
Kostenlos starten →